$ALK $ALXN: Credit Suisse Issues Top Outperform Stock Picks for 2019

Date: Saturday, December 8th, 2018

Stock(s) mentioned: ,

Source: 24/7 Wall St. (https://247wallst.com)

Summary: Alaska Air Group Inc. (NYSE: ALK) is the top airline pick at Credit Suisse, which has … Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) has a $156 target price at …

Full article address: https://247wallst.com/investing/2018/12/08/credit-suisse-top-2019-picks/

Related News:

$ABBV $ALXN $AIMT: 4 Blockbuster Drug Launches to Watch in 2019

$ALXN: Alexion teams up with Affibody AB to develop candidate for IgG …

$ALXN $ZEAL: Alexion teams up with Zealand Pharma in peptide therapies

$ALXN $ZEAL: Alexion and Zealand Pharma Announce Collaboration to Discover …

$ALXN: Alexion and Affibody Announce Partnership to Co-Develop Anti …

$PTC $ALXN: Skanska gets OK to pursue development in Somerville’s Union Square

$ALXN: Alexion Employees Raise Hands to Raise Awareness and …

$ALXN: (Eculizumab) as a Treatment for Patients with Neuromyelitis Optica …

$ALXN: FDA Grants Priority Review and Accepts sBLA of SOLIRIS …

$ALXN $MRK: Nomura bearish on Xencor in premarket analyst action

$AMP $ALXN $CCL: Alexion Pharma and Carnival Among Stocks Billionaire Ray Dalio Added in Q4

Latest News:

$MA: Mastercard Invests $300 Million in Dubai Payments Firm

$WINMQ: Neiman Marcus, in Debt Talks, Makes It Easier to Bet It Will Fail

$TEX: Terex (TEX) Down 11.4% Since Last Earnings Report: Can It Rebound?

$ZNGA $MGM $LVS $BYD: Gaming Industry Outlook: Macau Volatility Continues to Hurt

$CAPL $CKH $AR $WTI: W&T Becomes the Highest Bidder on 15 Blocks in GoM Auction

$NGVT $GG $NEM $KL: Newmont Unveils Special Dividend, Gets Mexican Anti-Trust Nod

$WEX $CPRT $ADP $BAH: WEX Unveils Buyout Plan for EG Group’s Fuel Card Business

$MLI $LAWS $AIN $GWW: Reasons to Hold Grainger (GWW) in Your Portfolio for Now

$SKYW $FLY $UNP $AZUL: Union Pacific (UNP) Strong on Freight Revenues & Dividends

$PEN $VAR $MASI $SYK: Masimo Gets FDA Clearance for Rad-67 Monitoring Device

$LH: Should Value Investors Consider Laboratory Corporation (LH)?